Aernoud T L Fiolet

4PUBLICATIONS
22CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Pacific Peoples epidemiologyMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 15, 2025
Cardiovascular Benefit of Colchicine in Relation to Baseline Risk: A Secondary Analysis of the LoDoCo2 Trial.

Niekbachsh Mohammadnia, Britta E Wesselink, Willem A Bax

|Feb 25, 2025
Sex Differences in Permanent Discontinuation of Trial Medication in Chronic Coronary Artery Disease: The LoDoCo2 Trial.

Marte F van der Bijl, Jenny van der Veen, Aernoud T L Fiolet

|Sep 25, 2024
Prediction of Severe Baseline Asymptomatic Carotid Stenosis and Subsequent Risk of Stroke and Cardiovascular Disease.

Michiel H F Poorthuis, Steven H J Hageman, Aernoud T L Fiolet

|Feb 21, 2022
Long-Term Efficacy of Colchicine in Patients With Chronic Coronary Disease: Insights From LoDoCo2.

Tjerk S J Opstal, Amber van Broekhoven, Aernoud T L Fiolet

Pageof 1